- Home
- LXRX vs OPP Comparison
LXRX vs OPP Comparison
Compare LXRX & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- OPP
- Stock Information
- Founded
- LXRX 1995
- OPP 2010
- Country
- LXRX United States
- OPP United States
- Employees
- LXRX N/A
- OPP N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- OPP Finance/Investors Services
- Sector
- LXRX Health Care
- OPP Finance
- Exchange
- LXRX Nasdaq
- OPP Nasdaq
- Market Cap
- LXRX 228.8M
- OPP 199.8M
- IPO Year
- LXRX 2000
- OPP N/A
- Fundamental
- Price
- LXRX $1.08
- OPP $8.53
- Analyst Decision
- LXRX Buy
- OPP
- Analyst Count
- LXRX 4
- OPP 0
- Target Price
- LXRX $3.67
- OPP N/A
- AVG Volume (30 Days)
- LXRX 5.0M
- OPP 108.0K
- Earning Date
- LXRX 07-31-2025
- OPP 01-01-0001
- Dividend Yield
- LXRX N/A
- OPP 14.41%
- EPS Growth
- LXRX N/A
- OPP N/A
- EPS
- LXRX N/A
- OPP N/A
- Revenue
- LXRX $31,213,000.00
- OPP N/A
- Revenue This Year
- LXRX N/A
- OPP N/A
- Revenue Next Year
- LXRX N/A
- OPP N/A
- P/E Ratio
- LXRX N/A
- OPP N/A
- Revenue Growth
- LXRX 1251.21
- OPP N/A
- 52 Week Low
- LXRX $0.28
- OPP $7.26
- 52 Week High
- LXRX $2.45
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- LXRX 66.94
- OPP 58.64
- Support Level
- LXRX $0.84
- OPP $8.44
- Resistance Level
- LXRX $1.19
- OPP $8.56
- Average True Range (ATR)
- LXRX 0.09
- OPP 0.07
- MACD
- LXRX 0.02
- OPP 0.00
- Stochastic Oscillator
- LXRX 76.60
- OPP 77.78
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.